Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: Results on tumor control and xerostomia

Radiation Oncology

Volumn 4, Issue , 2009, Pages 33-

  Cerezo, Laura ^a   Martín, Margarita ^a   López, Mario ^a   Marín, Alicia ^a   Gómez, Alberto ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PAROTID GLAND; QUESTIONNAIRE; RADIATION DOSE; SALIVARY GLAND FUNCTION; SALIVATION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND; XEROSTOMIA;

EID: 70350089373     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-4-33     Document Type: Article

References (27)

1. Eisbruch A, Kim HM, Terrell J, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001, 50:695-704.
2. Jensen AB, Hansen O, Jorgensen K, Bastholt L. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 1994, 33:487-91. 10.3109/02841869409083923, 7917360.
3. Grégoire V, Coche E, Cosnard G, Hamoir M, Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000, 56:135-50. 10.1016/S0167-8140(00)00202-4, 10927132.
4. Jackson SM, Hay HJ, Flores AD, Weir L, Wong FL, Schwindt C, Baerg B. Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 1999, 51:123-8. 10.1016/S0167-8140(99)00051-1, 10435802.
5. O'Sullivan B, Warde P, Grice B, Goh C, Payne D, Liu F-F, Waldron J, Bayley A, Irish J, Gullane P, Cummings B. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 2001, 51:332-43.
6. Jensen K, Overgaard M, Grau C. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol 2007, 85:90-7. 10.1016/j.radonc.2007.06.005, 17604141.
7. Corvò R, Foppiano F, Bacigalupo A, Berretta L, Benasso M, Vitale V. Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck: technical methodology and preliminary results. Tumori 2004, 90:66-72.
8. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure inpatients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002, 53:1174-84. 10.1016/S0360-3016(02)02881-X, 12128118.
9. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck 2007, 29:387-400. 10.1002/hed.20332, 16358297.
10. Cerezo L, Pérez L, López M, Cruz A. Ipsilateral irradiation for oropharynx and oral cavity cancer: a proposal for case selection and preliminary results. Radiother Oncol 2006, 81(Suppl 1):S500.
11. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972, 29:1446-49. 10.1002/1097-0142(197206)29:6<1446::AID-CNCR2820290604>3.0.CO;2-C, 5031238.
12. Bataini JP, Bernier J, Brugere J, Jaulerry C, Picco C, Brunin F. Natural history of neck disease in patients with squamous cell carcinoma of the oropharynx and pharyngolarynx. Radiother Oncol 1985, 3:245-55. 10.1016/S0167-8140(85)80033-5, 4001444.
13. Shah JP. Patterns of cervical lymph node metastases from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990, 160:405-9. 10.1016/S0002-9610(05)80554-9, 2221244.
14. UICC TNM classification of malignant tumours. 2006, 19-39.
15. Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen AB, Razavi D, Maher EJ, Kaasa S. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 1994, 33:879-85. 10.3109/02841869409098450, 7818919.
16. Arraras JI, Arias F, Tejedor M, Vera R, Prujá E, Marcos M, Martínez E, Valerdi JJ. El cuestionario de calidad de vida para tumores de cabeza y cuello de la EORTC QLQ-H&N35. Estudio de validación para nuestro país. Oncología 2001, 24(10):482-491.
17. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181. 10.1016/S1053-4296(03)00031-6, 12903007.
18. Eisbruch A, Rhodus N, Rosenthal D, Murphy B, Rasch C, Sonis S, Scarantino C, Brizel D. How should we measure and report radiotherapy-induced xerostomia?. Semin Radiat Oncol 2003, 13(3):226-34. 10.1016/S1053-4296(03)00033-X, 12903012.
19. Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. Radiother Oncol 2007, 85:83-9. 10.1016/j.radonc.2007.03.002, 17391790.
20. Jensen K, Lambertsen K, Torkov P, Dahl M, Jensen AB, Grau C. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol 2007, 46:1159-68. 10.1080/02841860701491041, 17851855.
21. Kagei K, Shirato H, Nishioka T, Arimoto T, Hashimoto S, Kaneko M, Ohmori K, Honma A, Inuyama Y, Miyasaka K. Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol 2000, 54:117-21. 10.1016/S0167-8140(99)00179-6, 10699473.
22. Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: Results of a prospective management approach. Int J Radiat Oncol Biol Phys 2009, 74(5):1365-70.
23. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005, 27:843-50. 10.1002/hed.20279, 16161069.
24. Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, Spector G. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 2001, 61:275-280. 10.1016/S0167-8140(01)00449-2, 11730997.
25. Parvathaneni U, Yu T, Mason BE, Ahamad A, Garden AS, Rosenthal DJ. Superior cochlear and parotid sparing and conformality by intensity modulated radiation therapy (IMRT) over wedge pair technique (WP) for unilateral treatment of tonsil carcinoma. Int J Radiat Oncol Biol Phys 2006, 66((3) Suppl 1):S189-190.
26. Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, Sauer R. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000, 18:3339-45.
27. Burlage FR, Roesnik JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A. Protection of salivary function by concomitant pilocarpine during radiotherapy: A double-blind, randomized, placebo-controlled study. Int J Radiat Oncol Biol Phys 2008, 70(1):14-22.